At ERS 2021, Ilona Jaspers, PhD, discusses some of the major health concerns associated with teenagers and young adults vaping.
There are a number of health-related concerns associated with young people vaping, according to Ilona Jaspers, PhD, director of toxicology and the deputy director of the Center for Environmental Medicine, Asthma, and Lung Biology at the Gillings School of Global Public Health at the University of North Carolina. She is also a professor of pediatrics, microbiology, and immunology.
Transcript
What are some health-related concerns associated with young people vaping?
So, there are a few. The most logical one is getting addicted to nicotine. That is something that is of great health concern because young individuals get addicted to nicotine a lot faster than older adults, and that has neurophysiological sort of reasons behind it. So, developing and establishing an addiction that basically follows you through a later portion of your life that's of health concern. With that also comes the concern about nicotine and its effect on neurodevelopment in young adults. So, those are 2 things. Those are nonrespiratory-related concerns.
Now, where my concerns command as an inhalation toxicologist is what does do long term or short term, meaning acutely long term to the lung. Does it have any longer term respiratory effects? And my concern is that it can either predispose you to another sort of challenge that you may encounter. It can exacerbate existing disease, such as asthma, or it can actually make you more prone to developing disease. So, those are the health concerns that that I am worried about.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More